PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 10965905-5 2000 In both cells, GH-induced MAP kinase activation was markedly blunted by the MEK1 inhibitor, PD98059, but not by the PKC inhibitor, GF109203X. 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one 92-99 mitogen activated protein kinase kinase 1 Rattus norvegicus 76-80 10965905-6 2000 Interestingly, pretreatment with the PI3K inhibitor, wortmannin (EC50 approximately 10 nM), significantly reduced GH-induced MAP kinase activation in both 32D-rbGHR and 32D-rbGHR-IRS-1 cells. Wortmannin 53-63 insulin receptor substrate 1 Rattus norvegicus 169-184 10965905-7 2000 This same pattern in both cells of IRS-1-dependent augmentation and IRS-1-independent wortmannin sensitivity was also observed for GH-induced activation of Akt and MEK1 (using state-specific antibody blotting for both), despite the lack of difference in GHR, JAK2, SHP-2, p85, Akt, Ras, Raf-1, MEK1, ERK1, or ERK2 abundance between the two cells. Wortmannin 86-96 insulin receptor substrate 1 Rattus norvegicus 68-73 10965905-7 2000 This same pattern in both cells of IRS-1-dependent augmentation and IRS-1-independent wortmannin sensitivity was also observed for GH-induced activation of Akt and MEK1 (using state-specific antibody blotting for both), despite the lack of difference in GHR, JAK2, SHP-2, p85, Akt, Ras, Raf-1, MEK1, ERK1, or ERK2 abundance between the two cells. Wortmannin 86-96 AKT serine/threonine kinase 1 Rattus norvegicus 156-159 10965905-7 2000 This same pattern in both cells of IRS-1-dependent augmentation and IRS-1-independent wortmannin sensitivity was also observed for GH-induced activation of Akt and MEK1 (using state-specific antibody blotting for both), despite the lack of difference in GHR, JAK2, SHP-2, p85, Akt, Ras, Raf-1, MEK1, ERK1, or ERK2 abundance between the two cells. Wortmannin 86-96 mitogen activated protein kinase kinase 1 Rattus norvegicus 164-168 10965905-7 2000 This same pattern in both cells of IRS-1-dependent augmentation and IRS-1-independent wortmannin sensitivity was also observed for GH-induced activation of Akt and MEK1 (using state-specific antibody blotting for both), despite the lack of difference in GHR, JAK2, SHP-2, p85, Akt, Ras, Raf-1, MEK1, ERK1, or ERK2 abundance between the two cells. Wortmannin 86-96 growth hormone receptor Rattus norvegicus 254-257 10965905-7 2000 This same pattern in both cells of IRS-1-dependent augmentation and IRS-1-independent wortmannin sensitivity was also observed for GH-induced activation of Akt and MEK1 (using state-specific antibody blotting for both), despite the lack of difference in GHR, JAK2, SHP-2, p85, Akt, Ras, Raf-1, MEK1, ERK1, or ERK2 abundance between the two cells. Wortmannin 86-96 Janus kinase 2 Rattus norvegicus 259-263 10965905-7 2000 This same pattern in both cells of IRS-1-dependent augmentation and IRS-1-independent wortmannin sensitivity was also observed for GH-induced activation of Akt and MEK1 (using state-specific antibody blotting for both), despite the lack of difference in GHR, JAK2, SHP-2, p85, Akt, Ras, Raf-1, MEK1, ERK1, or ERK2 abundance between the two cells. Wortmannin 86-96 protein tyrosine phosphatase, non-receptor type 11 Rattus norvegicus 265-270 10965905-7 2000 This same pattern in both cells of IRS-1-dependent augmentation and IRS-1-independent wortmannin sensitivity was also observed for GH-induced activation of Akt and MEK1 (using state-specific antibody blotting for both), despite the lack of difference in GHR, JAK2, SHP-2, p85, Akt, Ras, Raf-1, MEK1, ERK1, or ERK2 abundance between the two cells. Wortmannin 86-96 AKT serine/threonine kinase 1 Rattus norvegicus 277-280 10965905-7 2000 This same pattern in both cells of IRS-1-dependent augmentation and IRS-1-independent wortmannin sensitivity was also observed for GH-induced activation of Akt and MEK1 (using state-specific antibody blotting for both), despite the lack of difference in GHR, JAK2, SHP-2, p85, Akt, Ras, Raf-1, MEK1, ERK1, or ERK2 abundance between the two cells. Wortmannin 86-96 Raf-1 proto-oncogene, serine/threonine kinase Rattus norvegicus 287-292 10965905-7 2000 This same pattern in both cells of IRS-1-dependent augmentation and IRS-1-independent wortmannin sensitivity was also observed for GH-induced activation of Akt and MEK1 (using state-specific antibody blotting for both), despite the lack of difference in GHR, JAK2, SHP-2, p85, Akt, Ras, Raf-1, MEK1, ERK1, or ERK2 abundance between the two cells. Wortmannin 86-96 mitogen activated protein kinase kinase 1 Rattus norvegicus 294-298 10965905-7 2000 This same pattern in both cells of IRS-1-dependent augmentation and IRS-1-independent wortmannin sensitivity was also observed for GH-induced activation of Akt and MEK1 (using state-specific antibody blotting for both), despite the lack of difference in GHR, JAK2, SHP-2, p85, Akt, Ras, Raf-1, MEK1, ERK1, or ERK2 abundance between the two cells. Wortmannin 86-96 mitogen activated protein kinase 3 Rattus norvegicus 300-304 10965905-7 2000 This same pattern in both cells of IRS-1-dependent augmentation and IRS-1-independent wortmannin sensitivity was also observed for GH-induced activation of Akt and MEK1 (using state-specific antibody blotting for both), despite the lack of difference in GHR, JAK2, SHP-2, p85, Akt, Ras, Raf-1, MEK1, ERK1, or ERK2 abundance between the two cells. Wortmannin 86-96 mitogen activated protein kinase 1 Rattus norvegicus 309-313 10965905-8 2000 A different PI3K inhibitor, LY294002 (50 microM), substantially inhibited (roughly 72%) GH-induced MAP kinase activation in 32D-rbGHR-IRS-1 cells, but only marginally (and statistically insignificantly) inhibited GH-induced MAP kinase activation in 32D-rbGHR cells. 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 28-36 isoleucine-tRNA synthetase Mus musculus 134-137 10965905-9 2000 Because GH-induced Akt activation was completely inhibited in both cells by the same concentration of LY294002, these findings indicate that the wortmannin sensitivity of both the IRS-1-independent and -dependent GH-induced MAP kinase activation may reflect the activity of another wortmannin-sensitive target(s) in addition to PI3K in mediation of GH-induced MAP kinase activation in these cells. 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 102-110 AKT serine/threonine kinase 1 Rattus norvegicus 19-22 10965905-9 2000 Because GH-induced Akt activation was completely inhibited in both cells by the same concentration of LY294002, these findings indicate that the wortmannin sensitivity of both the IRS-1-independent and -dependent GH-induced MAP kinase activation may reflect the activity of another wortmannin-sensitive target(s) in addition to PI3K in mediation of GH-induced MAP kinase activation in these cells. 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 102-110 insulin receptor substrate 1 Rattus norvegicus 180-185 10965905-9 2000 Because GH-induced Akt activation was completely inhibited in both cells by the same concentration of LY294002, these findings indicate that the wortmannin sensitivity of both the IRS-1-independent and -dependent GH-induced MAP kinase activation may reflect the activity of another wortmannin-sensitive target(s) in addition to PI3K in mediation of GH-induced MAP kinase activation in these cells. Wortmannin 145-155 AKT serine/threonine kinase 1 Rattus norvegicus 19-22 10965905-9 2000 Because GH-induced Akt activation was completely inhibited in both cells by the same concentration of LY294002, these findings indicate that the wortmannin sensitivity of both the IRS-1-independent and -dependent GH-induced MAP kinase activation may reflect the activity of another wortmannin-sensitive target(s) in addition to PI3K in mediation of GH-induced MAP kinase activation in these cells. Wortmannin 145-155 insulin receptor substrate 1 Rattus norvegicus 180-185 10965905-10 2000 Notably, GH-induced STAT5 tyrosine phosphorylation, unlike Akt or MAPK activation, did not differ between the cells. Tyrosine 26-34 signal transducer and activator of transcription 5A Rattus norvegicus 20-25 10965905-12 2000 These data indicate that while GH induces tyrosine phosphorylation of STAT5 and activation of the Ras/Raf/MEK1/MAPK and PI3K pathways, IRS-1 expression augments the latter two more than the former. Tyrosine 42-50 signal transducer and activator of transcription 5A Rattus norvegicus 70-75